Is AntAngioCOOL safe to use?

AntAngioCOOL has no known vulnerabilities on the latest version (1.2). DepScope rates its health at 42/100 (high risk).

What is the latest version of AntAngioCOOL?

The latest version of AntAngioCOOL is 1.2, released 2016-08-01.

Does AntAngioCOOL have known vulnerabilities?

No known vulnerabilities on the latest version of AntAngioCOOL.

Is AntAngioCOOL deprecated?

No, AntAngioCOOL is actively maintained. Latest release: 1.2 (2016-08-01).

What are alternatives to AntAngioCOOL?

DepScope has no curated alternatives for AntAngioCOOL at this time.

What license does AntAngioCOOL use?

AntAngioCOOL is licensed under GPL-2.

AntAngioCOOL

cranv1.2

Anti-Angiogenic Peptide Prediction. Machine learning based package to predict anti-angiogenic peptides using heterogeneous sequence descriptors. 'AntAngioCOOL' exploits five descriptor types of a peptide of interest to do prediction including: pseudo amino acid composition, k-mer composition, k-mer composition (reduced alphabet), phys

License GPL-2strong copyleft0 versions1 maintainers4 deps139 weekly dl

https://CRAN.R-project.org/package=AntAngioCOOL

/ 100

Health

safe to use

[email protected] is safe to use (health: 42/100)

Health breakdown0 – 100

0/25

maintenance

3/20

popularity

25/25

security

12/15

maturity

2/15

community

Vulnerabilities

none known

Health History

Dependency Tree

License Audit

Dependencies (4)

caret rJava RWeka rpart

API access

Get this data programmatically — free, no authentication.

curl https://depscope.dev/api/check/cran/AntAngioCOOL

First published · 2016-08-01 08:03:24

Last updated · 2016-08-01T14:01:06+00:00